New approaches to rationale pharmacotherapy of trigeminal neuralgia based on personalized medicine principles
Abstract
Optimization of pharmacotherapy (selection of optimal doses and dosing intervals) is a major objective of clinical pharmacology. This objective may be achieved, in part, by implementation of modern pharmacokinetic approaches and the use of therapeutic drug monitoring that consists in selection of an appropriate dose level and dosing interval based on information about drug concentrations at certain timepoints. This is particularly important for drugs with a narrow therapeutic range. The authors of the article advocate the usefulness of therapeutic drug monitoring in treating exacerbation of trigeminal neuralgia with carbamazepin and evaluate practical relevance of development of a new phenotyping method that could be used to increase pharmacotherapy efficiency and safety.
About the Authors
V. V. Arkhipov
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
A. V. Sokolov
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
T. A. Rodina
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
D. L. Pozdnyakov
State Institution of Health «Medsantrud City Clinical Hospital № 23» of Department of Health
Russian Federation
Russian Federation
Е. А. Sокоvа
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
References
1. Gusev EN, Belousov YuB, Geht AB, Bondareva IB, Sokolov AV, Tischenkova IF. Treatment of epilepsy: Rational dosing of anticonvulsants. St. Petersburg: Rech; 2000 (in Russian).
2. Karlov VA. Treatment of nervous diseases. Moscow: Meditsina; 2004 (in Russian).
3. Kukes VG, Berry D, eds. Therapeutic drug monitoring: a tool for personalized medicine. Methodical recommendations. Moscow: Mezhdunarodnaya assotsiatsiya klinicheskih farmakologov i farmatsevtov; 2013 (in Russian).
4. Megdyatov RS. Trigeminal neuralgia. Moscow: Meditsina; 1999 (in Russian).
5. Kukes VG, ed. Personalized Medicine: Clinical and pharmacological aspects. Moscow: Mezhdunarodnaya assotsiatsiya klinicheskih farmakologov i farmatsevtov; 2014 (in Russian).
6. Stepanchenko AV, Grechko VE, Neymatov EM. Cranial nerves in normal and pathological conditions. Moscow: MNPI; 2001 (in Russian).
7. Kukes VG, ed. Handbook of drugs that are metabolized in the human body. Moscow: Mezhdunarodnaya assotsiatsiya klinicheskih farmakologov i farmatsevtov; 2013 (in Russian).
8. Holodov LE, Yakovlev VP. Clinical pharmacokinetics. Moscow: Meditsina; 1985 (in Russian).
9. Pienimäki P, Hartikainen AL, Arvela P, Partanen T, Herva R, Pelkonen O, Vähäkangas K. Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood. Epilepsia 1995; 36(3): 241–8.
10. Larry A. Applied Clinical Pharmacokinetics. McGraw-Hill; 2008.
11. Hung CC, Chang WL, Ho JL, Tai JJ, Hsieh TJ, Huang HC, Hsieh YW, Liou HH. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. Pharmacogenomics 2012 Jan; 13(2): 159–69.
12. Serralheiro A, Alves G, Fortuna A, Rocha M, Falcão A. First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-transdihydroxy-10,11- dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2013; Apr 15: 925.
13. Sato J, Saitoh T, Notani K, Fukuda H, Kaneyama K, Segami N. Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; PMID 14716252.
14. Guo-qiang Chen, Xiao-song Wang, Lin Wang, Jia-ping Zheng. Arterial compression of nerve is the primary cause of trigeminal neuralgia. Neurol Sci. 2014; 35(1): 61–66.
15. Kukes VG, Grachev SV, Sychev DA, et al. Metabolism of drugs. Scientific basis of personalized medicine. M .: GEOTAR-Media; 2008 (in Russian).
16. USP Drug Information. Volume I: Drug Information for the Health Care Professional.24th ed. Bethesda: Greenwood Village Co; 2004.
17. Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommision on therapeutic drug monitoring, ILAE commission on therapeutic strategies. Epilepsia 2008; (49): 1239–76.
18. Rambeck B, May TW, Jürgens MU, Blankenhorn V, Jürges U, Korn-Merker E, Sälke- Kellermann A. Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge system. Ther Drug Monit. 1994; (16): 608–12.
19. Sánchez A, Garcia R, Abadin JA, Durán JA. Determination of free serum carbamazepine by protein precipitation with sulphosalicylic acid. Pharm Pharmacol Commun. 1999; (5): 435–438.
20. 20. Lanças FM, Sozza MA, Queiroz ME. Simultaneous plasma lamotrigine analysis with carbamazepine, carbamazepine-10,11-epoxide, primidone, phenytoin, phenobarbital, and PEMA by micellar electrokinetic capillary chromatography (MECC). J Anal Toxicol 2003; (27): 304–308.
21. Romanyshyn LA, Wichmann JK, Kucharczyk N, Shumaker RC, Ward D, Sofia RD. Simultaneous determination of felbamate, primidone, Phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin and one phenytoin metabolite in human plasma by high-performance liquid chromatography. Ther Drug Monit. 1994; (16): 90–99.
22. Bhatti MM, Hanson GD, Schultz L. Simultaneous determination of phenytoin, carbamazepine, and 10,11-carbamazepine epoxide in human serum by high-performance liquid chromatography with ultra-violet detection. J Pharm Biomed Anal. 1998; (16): 233–1240.
23. Queiroz ME, Silva SM, Carvalho D, Lancas FM. Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, Phenobarbital, and primidone in human plasma by SPME-GC-TSD. J Chromatogr Sci. 2002; 40: 219–23.
24. Yoshida T, Imai K, Motohashi S, Hamano S, Sato M. Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high- performance liquid chromatography. J Pharm Biomed Anal. 2006; (41): 1386–90.
25. Oh E, Ban E, Woo JS, Kim CK. Analysis of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma using high-performance liquid chromatography. Anal Bioanal Chem. 2006; (386): 1931–36.
26. Leite CE, Petersen GO, Lunardelli A, Thiesen FV. A high-performance liquid chromatography method for the determination of carbamazepine and carbamazepine-10,11-epoxide and its comparison with chemiluminescent immunoassay. Clin Chem Lab Med. 2009; (47): 458–63.
27. Breton H, Cociglio M, Bressolle F, Peyriere H, Blayac JP, Hillaire-Buys D. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; (828): 80–90.
28. Subramanian M, Birnbaum AK, Remmel RP. High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. Ther Drug Monit. 2008; (30): 347–56.
29. Vuckovic D, de Lannoy I, Gien B, et alYang Y, Musteata FM, Shirey R, Sidisky L, Pawliszyn J. In vivo solid-phase microextration for single rodent pharmacokinetics studies of carbamazepine and carbamazepine-10, 11-epoxide in mice. J Chromatogr A 2010; (1218): 3367–75.
Review
For citations:
Arkhipov V.V., Sokolov A.V., Rodina T.A., Pozdnyakov D.L., Sокоvа Е.А. New approaches to rationale pharmacotherapy of trigeminal neuralgia based on personalized medicine principles. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2015;(1):16-20. (In Russ.)
Views:
551
Email this article 